RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
MENEGATTI E
Collezione ASL Città di Torino
Items : 42
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino
AOU Città della Salute di Torino
Sciascia S; Roccatello D; Barinotti A; Menegatti E; Baldovino S; Foddai SG; Cioffi M; Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L;
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation. in Frontiers in immunology / Front Immunol. 2024 Mar 14;15:1351446. doi: 10.3389/fimmu.2024.1351446. eCollection 2024.
2024
ASL Città di Torino
Sciascia S; Rodríguez-Carrio J; Roccatello D; Suárez A; Foddai SG; Menegatti E; Radin M; Barinotti A; Cecchi I;
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Baldovino S; Barinotti A; Guidetti MG; Cinnirella G; Crosasso P; Cecchi I; Radin M; Foddai SG; Fenoglio R; Rilat MLA; Sciascia S;
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain. in Autoimmunity reviews / Autoimmun Rev. 2023 Nov;22(11):103454. doi: 10.1016/j.autrev.2023.103454. Epub 2023 Sep 22.
2023
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Elnaz R; Rubini E; Aluf O; Barinotti A; Cecchi I; Radin M; Manfredi M; Benucci M; Infantino M; Foddai S;
Identifying subsets of patients with undifferentiated connective tissue disease: Results from a prospective, real-world experience using particle-based multi-analyte technology. in Autoimmunity reviews / Autoimmun Rev. 2023 May;22(5):103298. doi: 10.1016/j.autrev.2023.103298. Epub 2023 Feb 14.
2023
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Bentow C; Rossi D; Mahler M; Miraglia P; Arbrile M; Wilson Jones G; Barinotti A; Radin M; Cecchi I;
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Vaccarino A; Fenoglio R; Rossi D; Rubini E; Barinotti A; Cecchi I; Radin M; Sciascia S;
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review. in International journal of molecular sciences / Int J Mol Sci. 2023 Feb 3;24(3):3041. doi: 10.3390/ijms24033041.
2023
ASL Città di Torino
Roccatello D; Menegatti E; Barinotti A; Foddai SG; Rilat L; Cecchi I; Miraglia P; Medica D; Arbrile M; Radin M; Sciascia S;
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies. in Journal of clinical pathology / J Clin Pathol. 2023 Dec;76(12):839-846. doi: 10.1136/jcp-2022-208199. Epub 2022 Sep 13.
2023
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Rubini E; Foddai SG; Cecchi I; Barinotti A; Radin M;
Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease. in BMC rheumatology / BMC Rheumatol. 2023 Apr 5;7(1):6. doi: 10.1186/s41927-023-00330-1.
2023
AOU Città della Salute di Torino
ASL Città di Torino
Lanzetta I; Fenoglio R; Menegatti E; Roccatello D; Charbonier N; Barreca A; Cecchi I; Sciascia S; Giarin M; Radin M; Miraglia P;
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-?2GPI I domain in Autoimmunity Reviews
2023
ASL Città di Torino
Infantino M; Foddai S; Manfredi M; Benucci M; Radin M; Cecchi I; Barinotti A; Aluf O; Rubini E; Elnaz R; Menegatti E; Roccatello D; Sciascia S;
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head. in International journal of cardiology / Int J Cardiol. 2022 Sep 15;363:185-189. doi: 10.1016/j.ijcard.2022.06.040. Epub 2022 Jun 14.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Rubini E; Arbrile M; Foddai SG; Cecchi I; Radin M; Barinotti A;
Pregnancy outcomes in Behçet's disease: Results from a monocentric cohort. in Journal of reproductive immunology / J Reprod Immunol. 2022 Sep;153:103682. doi: 10.1016/j.jri.2022.103682. Epub 2022 Aug 1.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Menegatti E; Rossi D; Radin M; Arbrile M;
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience. in Journal of clinical medicine / J Clin Med. 2022 May 25;11(11):2977. doi: 10.3390/jcm11112977.
2022
ASL Città di Torino
Roccatello D; Fenoglio R; Baldovino S; Rossi D; Terzolo E; Menegatti E; Cecchi I; Radin M; Barinotti A; Sciascia S;
Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino
Sciascia S; Roccatello D; Rossi D; Menegatti E; Baldovino S; Barinotti A; Favuzzi MD; Crosasso P; Milone V; Osella S; Di Gregorio F; Di Nunzio P; Buccarano N; Arbrile M; Cecchi I; Radin M;
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Rubini E; Cecchi I; Barinotti A; Foddai SG; Radin M;
Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino
Roccatello D; Sciascia S; Baldovino S; Menegatti E; Rossi D; Radin M; Arbrile M;
Improving diagnosis for rare diseases: the experience of the Italian undiagnosed Rare diseases network. in Italian journal of pediatrics / Ital J Pediatr. 2020 Sep 14;46(1):130. doi: 10.1186/s13052-020-00883-8.
2020
ASL Città di Torino
Sangiuolo F; Novelli G; Neri M; Ferlini A; Da Riol RM; Bembi B; Iatropoulos P; Daina E; Remuzzi G; Menegatti E; Sciascia S; Roccatello D; Baldovino S; Polizzi A; De Stefano MC; Floridia G; Salvatore M; Brancati F; Taruscio D;
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome. in Autoimmunity reviews / Autoimmun Rev. 2020 Oct;19(10):102641. doi: 10.1016/j.autrev.2020.102641. Epub 2020 Aug 13.
2020
ASL Città di Torino
Mahler M; Roccatello D; Menegatti E; Fenoglio R; Baldovino S; Foddai SG; Rubini E; Cecchi I; Casas S; Bentow C; Seaman A; Ramirez C; Radin M; Sciascia S;
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities. in Journal of thrombosis and haemostasis : JTH / J Thromb Haemost. 2020 Nov;18(11):2921-2928. doi: 10.1111/jth.15053. Epub 2020 Sep 21.
2020
ASL Città di Torino
AOU Città della Salute di Torino
Marozio L; Benedetto C; Donati Marello B; Roccatello D; Manetta T; Mengozzi G; Menegatti E; Barinotti A; Orpheu G; Rubini E; Gaito S; Cecchi I; Radin M; Foddai SG; Sciascia S;
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring. in Autoimmunity reviews / Autoimmun Rev. 2020 Feb;19(2):102449. doi: 10.1016/j.autrev.2019.102449. Epub 2019 Dec 12.
2020
ASL Città di Torino
Roccatello D; Menegatti E; Alba P; Escudero A; Foddai SG; Rubini E; Guiñazu F; Ladehesa PL; Radin M; Rossi D; Massara C; Cecchi I; Sciascia S;
Genetic Factors in Antiphospholipid Syndrome: Preliminary Experience with Whole Exome Sequencing. in International journal of molecular sciences / Int J Mol Sci. 2020 Dec 15;21(24):9551. doi: 10.3390/ijms21249551.
2020
ASL Città di Torino
Menegatti E; Sciascia S; Roccatello D; Rubini E; Foddai SG; Cecchi I; Radin M; Barinotti A;
Treatment of antiphospholipid syndrome. in Clinical immunology (Orlando, Fla.) / Clin Immunol. 2020 Dec;221:108597. doi: 10.1016/j.clim.2020.108597. Epub 2020 Sep 19.
2020
ASL Città di Torino
Sciascia S; Menegatti E; Roccatello D; Barinotti A; Rubini E; Foddai SG; Radin M; Cecchi I;
Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients in Autoimmunity Reviews
2020
ASL Città di Torino
Lopez-Pedrera C; Menegatti E; Roccatello D; Aguirre Zamorano MA; Patiño Trives AM; Perez-Sanchez L; Scudeler L; Barbarroja Puerto N; Arias de la Rosa I; Radin M; Sciascia S; Perez-Sanchez C; Cecchi I;
Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2019 Oct 1;58(10):1870-1872. doi: 10.1093/rheumatology/kez166.
2019
ASL Città di Torino
López Pedrera C; Roccatello D; Collantes E; Sciascia S; Menegatti E; Barbarroja N; Pérez-Sánchez C; Aguirre MÁ; Rubini E; Cecchi I; Radin M; Arias de la Rosa I;
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study. in Frontiers in immunology / Front Immunol. 2019 Mar 5;10:376. doi: 10.3389/fimmu.2019.00376. eCollection 2019.
2019
ASL Città di Torino
AOU Città della Salute di Torino
AOU Novara
Mahler M; Vaccarino A; Ferro M; Baldovino S; Muccini E; Pergolini P; Mengozzi G; Montaruli B; Rolla R; Scotta A; Rubini E; Radin M; Cecchi I; Sciascia S; Menegatti E; Roccatello D;
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome. in Oncotarget / Oncotarget. 2018 Jun 22;9(48):28799-28804. doi: 10.18632/oncotarget.25612. eCollection 2018 Jun 22.
2018
ASL Città di Torino
Roccatello D; Menegatti E; Ferro M; Quattrocchio G; Mesiano P; Beltrame G; Fenoglio R; Sciascia S;
Safety of outpatient percutaneous native renal biopsy in systemic autoimmune diseases: results from a monocentric cohort. in Lupus / Lupus. 2018 Jul;27(8):1393-1394. doi: 10.1177/0961203317751645. Epub 2018 Jan 11.
2018
ASL Città di Torino
Menegatti E; Baldovino S; Sandrone M; Radin M; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;
Outpatient percutaneous native renal biopsy: safety profile in a large monocentric cohort. in BMJ open / BMJ Open. 2017 Jun 21;7(6):e015243. doi: 10.1136/bmjopen-2016-015243.
2017
ASL Città di Torino
Baldovino S; Menegatti E; Solfietti L; Naretto C; Bazzan M; Rossi D; Sciascia S; Roccatello D;
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents. in Oncotarget / Oncotarget. 2017 Jun 20;8(25):41764-41777. doi: 10.18632/oncotarget.16986.
2017
ASL Città di Torino
Menegatti E; Fenoglio R; Solfietti L; Rossi D; Sciascia S; Roccatello D; Baldovino S;
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study. in Oncotarget / Oncotarget. 2017 May 23;8(32):52072-52077. doi: 10.18632/oncotarget.18120. eCollection 2017 Aug 8.
2017
ASL Città di Torino
Menegatti E; Baldovino S; Fenoglio R; Radin M; Naretto C; Alpa M; Sciascia S; Rossi D; Roccatello D;
Immunological Rare Diseases. in Advances in experimental medicine and biology / Adv Exp Med Biol. 2017;1031:497-509. doi: 10.1007/978-3-319-67144-4_26.
2017
ASL Città di Torino
Baldovino S; Menegatti E; Roccatello D; Sciascia S;
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study in American Journal of Nephrology
2017
ASL Città di Torino
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E;
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature. in Autoimmunity reviews / Autoimmun Rev. 2016 Jun;15(6):529-38. doi: 10.1016/j.autrev.2016.02.014. Epub 2016 Feb 11.
2016
ASL Città di Torino
Menegatti E; Baldovino S; Fenoglio R; Naretto C; Solfietti L; Di Simone D; Sciascia S; Roccatello D;
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay. in Clinical and molecular allergy : CMA / Clin Mol Allergy. 2016 Jul 15;14:6. doi: 10.1186/s12948-016-0043-2. eCollection 2016.
2016
ASL Città di Torino
Roccatello D; Menegatti E; Erkan D; Cuadrado MJ; Radin M; Schreiber K; Solfietti L; Baldovino S; Sciascia S;
Improved (4 Plus 2) Rituximab Protocol for Severe Cases of Mixed Cryoglobulinemia: A 6-Year Observational Study. in American journal of nephrology / Am J Nephrol. 2016;43(4):251-60. doi: 10.1159/000445841. Epub 2016 Apr 29.
2016
ASL Città di Torino
Alpa M; Naretto C; Di Simone D; Menegatti E; Rossi D; Sciascia S; Baldovino S; Roccatello D;
Thrombin generation assay and autoimmune bullous diseases in Oral Diseases
2016
ASL Città di Torino
Cabras M; Arduino PG; Sciascia S; Radin M; Solfietti L; Di Simone D; Giancaspero K; Menegatti E; Baldovino S;
A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment. in Autoimmunity reviews / Autoimmun Rev. 2015 Dec;14(12):1123-30. doi: 10.1016/j.autrev.2015.07.017. Epub 2015 Aug 2.
2015
ASL Città di Torino
Simoncini M; Di Simone D; Naretto C; Alpa M; Rossi D; Baldovino S; Sciascia S; Roccatello D; Menegatti E;
C1 esterase inhibitor deficiency and SLE: A case report and review of the literature in Molecular Immunology
2013
ASL Città di Torino
Baldovino S; Naretto C; Mereuta M; Sciascia S; Manna E; Salussolia I; Strani G; Giancaspero K; Menegatti E; Roccatello D;
Lab-on-a-chip: Emerging analytical platforms for immune-mediated diseases in Autoimmunity Reviews
2013
ASL Città di Torino
Menegatti E; Berardi D; Messina M; Ferrante I; Giachino O; Spagnolo B; Restagno G; Cognolato L; Roccatello D;
Rituximab in cryoglobulinemic peripheral neuropathy. in Journal of neurology / J Neurol. 2009 Jul;256(7):1076-82. doi: 10.1007/s00415-009-5072-z. Epub 2009 Mar 5.
2009
ASL Città di Torino
Napoli F; Naretto C; Roccatello D; Menegatti E; Baldovino S; Cavallo R;
Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. in Autoimmunity reviews / Autoimmun Rev. 2008 Oct;8(1):56-8. doi: 10.1016/j.autrev.2008.07.027. Epub 2008 Aug 12.
2008
ASL Città di Torino
Baldovino S; Rossi D; Ferrero B; Cavallo R; Naretto C; Menegatti E; Di Simone D; Napoli F; La Grotta R; Sena LM; Roccatello D; Alpa M;
Effects of ANCA-positive sera on the generation of oxygen free radicals by neutrophils. in Contributions to nephrology
1992
ASL Città di Torino
Rollino C; Roccatello D; Cavalli G; Amprimo MC; Quattrocchio G; Menegatti E; Mediate I; Ferrero A; Basolo B; Ferro M;